This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anonymous (1997) Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Consensus statement of the joint Steering Committees of the Unexplained cardiac arrest Registry of Europe and of the Idiopathic ventricular fibrillation Registry of the United States. Circulation 95:265–272
Kontny F, Dale J (1990) Self-terminating idiopathic ventricular fibrillation presenting as syncope: a 40-year follow-up report. J Int Med 227:211–213
Fish JM, Di Diego JM, Nesterenko V et al (2004) Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization. Implications for biventricular pacing. Circulation 109:2136–2142
Fish JM, Antzelevitch C (2004) Link between hypothermia and the Brugada syndrome. J Cardiovasc Electrophysiol 15:942–944
Antzelevitch C, Brugada P, Borggrefe M et al (2005) Brugada syndrome. Report of the Second Consensus Conference. Circulation 111:659–670
Antzelevitch C, Belardinelli L, Zygmunt AC et al (2004) Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 110:904–910
Antzelevitch C, Extramiana F (2004) Amplified transmural dispersion of repolarization as the basis for arrhythmogenesis in a canine ventricular-wedge model of short-QT syndrome. Circulation 110:3661–3666
Gussak H et al (1995) ECG phenomenon called the J-wave. J Electrocardiol 28:49–58
Yan GX, Antzelevitch C (1996) Cellular bases for the electrocardiographic J-wave. Circulation 93:372–379
Fish JM, Antzelevitch C (2003) Cellular and ionic bases for the sex related difference in the manifestation of the Brugada syndrome and progressive conduction disease phenotypes. J Electrocardiol 36:173–179
Haverkamp W, Rolf S, Eckardt L et al (2005) Long QT syndrome and Brugada syndrome. Drugs, ablation or ICD? Herz 30(2):111–118
Watanabe H, Chinushi M, Washizuka T et al (2005) Variable electrocardiographic effects of short term quinidine sulphate administration in Brugada syndrome. Pacing Clin Electrophysiol 28(5):372–377
Mohler PJ, Bennett V (2005) Ankyrin-based cardiac arrhythmias: a new class of channelopathies due to loss of cellular targeting. Curr Opin Cardiol 20(3):189–193
Rossenbacker T, Carroll SJ, Liu H et al (2004) Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction diseases and Brugada syndrome to sudden cardiac death. Heart Rhythm 1(5):610–615
Ackerman MJ, Splawski I, Makielski JC et al (2004) Spectrum and prevalence of cardiac sodium channel variance among black, white, Asian and Hispanic individuals: implications fpr arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 1(5):600–607
Santambrogio LG, Mencherini S, Fuardo M et al (2005) The surgical patients with Brugada syndrome: a four cases clinical experience. Anesth Analg 100(5):1263–1266
Peng J, Cui YK, Yi SD et al (2005) Fever and Brugada syndrome: report of 21 cases. Di Yi Jun Yi Da Xue Xue Bao 25(4):432–434
Chow BJ, Gollob M, Birnie D (2005) Brugada syndrome precipitated by a tricyclic antidepressant. Heart 91(5):651
Gaita F, Giustetto C, Bianchi F et al (2004) Short QT syndrome: pharmacological treatment. J Am Coll Cardiol 43:1494–1499
Priori S, Napolitano C, Memmi M et al (2002) Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106:69–74
Hong K, Brugada J, Oliva A et al (2004) Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCNA mutations. Circulation 110:3023–3027
Marks AR (2002) Clinical implications of cardiac ryanodine receptor/calcium release channel mutations linked to sudden cardiac death. Circulation 106:8–10
Eckardt L, Probst V, Smits JPP et al (2005) Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 111:257–263
Hong K, Antzelevitch C, Brugada P et al (2004) Brugada syndrome: 12 years of progression. Acta Med Okayama 58:255–261
Naccarella F, Bresciani B, Lepera G et al (2005) Prospective follow-up of thirteen Brugada patients and of their families (200 members). Non-invasive evaluation and drug tests. Proceedings of the First annual congress of the European cardiac arrhythmia society. Marseille, April 10–12 2005 (in press)
Corrado D, Leoni L, Naccarella F et al (2003) Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy dysplasia. Circulation 108:3084–3091
Camm AJ, Malik M, Yap GY (2004) Acquired long QT syndrome. Blackwell Futura Publishing, Philadelphia
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Italia
About this chapter
Cite this chapter
Naccarella, F. et al. (2006). Fever and Other Precipitants of Ventricular Arrhythmias in Brugada Syndrome: Do We Know How They Act?. In: Raviele, A. (eds) Cardiac Arrhythmias 2005. Springer, Milano. https://doi.org/10.1007/88-470-0371-7_37
Download citation
DOI: https://doi.org/10.1007/88-470-0371-7_37
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0370-5
Online ISBN: 978-88-470-0371-2
eBook Packages: MedicineMedicine (R0)